FDA Clearance Tracker · P100044-S020
PROPEL
Last checked: Nov 20, 2026Latest source record: Aug 24, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Aug 24, 2016
Approved
Time to decision
152 days
Received Mar 25, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P100044-S020
- Device name
- PROPEL
- Applicant
- Intersect Ent.
- Applicant location
- Menlo Park, CA
- Received
- Mar 25, 2016
- Decided
- Aug 24, 2016
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P100044
Device type
- Device type
- Drug-eluting sinus stent (OWO)
- Device class
- Class III
- Specialty
- Otolaryngology (ENT)
FDA's approval statement
As written in FDA's record.
Approval for a manufacturing site located at Synergy Health AST, LLC, Lakevillle Hwy, Suite 120, Petaluma, CA 94954 as a backup sterilization facility for the Propel and Propel Mini Sinus Implants.
Source documents
Other decisions for Intersect Ent.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- VenSure LightGuide510(k)
K212774 · Decided Feb 4, 2022 · 156 days after receipt
Device type: Instrument, Ent Manual Surgical (LRC) · Otolaryngology (ENT)
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.